245 related articles for article (PubMed ID: 25014002)
1. Hormone secretion by pituitary adenomas is characterized by increased disorderliness and spikiness but more regular pulsing.
Roelfsema F; Pereira AM; Biermasz NR; Veldhuis JD
J Clin Endocrinol Metab; 2014 Oct; 99(10):3836-44. PubMed ID: 25014002
[TBL] [Abstract][Full Text] [Related]
2. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
Kobayashi T
Prog Neurol Surg; 2009; 22():77-95. PubMed ID: 18948721
[TBL] [Abstract][Full Text] [Related]
4. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.
Oki K; Yamane K; Oda Y; Kamei N; Watanabe H; Tominaga A; Amatya VJ; Oki Y; Kohno N
J Neurosurg; 2009 Feb; 110(2):369-73. PubMed ID: 18991502
[TBL] [Abstract][Full Text] [Related]
5. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
6. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
9. A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomas.
Regazzo D; Avallone S; MacSweeney CP; Sergeev E; Howe D; Godwood A; Bennett KA; Brown AJH; Barnes M; Occhi G; Barbot M; Faggian D; Tropeano MP; Losa M; Lasio G; Scaroni C; Pecori Giraldi F
Eur J Endocrinol; 2024 Jan; 190(1):K8-K16. PubMed ID: 38123488
[TBL] [Abstract][Full Text] [Related]
10. A Case of acromegaly associated with subclinical Cushing's disease.
Tsuchiya K; Ohta K; Yoshimoto T; Doi M; Izumiyama H; Hirata Y
Endocr J; 2006 Oct; 53(5):679-85. PubMed ID: 16926523
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
14. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
15. Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis.
Selek A; Cetinarslan B; Gurbuz Y; Tarkun I; Canturk Z; Cabuk B
Endocrine; 2015 May; 49(1):250-7. PubMed ID: 25300784
[TBL] [Abstract][Full Text] [Related]
16. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
[TBL] [Abstract][Full Text] [Related]
17. Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas.
Groote Veldman R; van den Berg G; Pincus SM; Frölich M; Veldhuis JD; Roelfsema F
Eur J Endocrinol; 1999 Mar; 140(3):192-200. PubMed ID: 10216513
[TBL] [Abstract][Full Text] [Related]
18. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas.
Castinetti F; Nagai M; Morange I; Dufour H; Caron P; Chanson P; Cortet-Rudelli C; Kuhn JM; Conte-Devolx B; Regis J; Brue T
J Clin Endocrinol Metab; 2009 Sep; 94(9):3400-7. PubMed ID: 19509108
[TBL] [Abstract][Full Text] [Related]
20. Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
Swords FM; Monson JP; Besser GM; Chew SL; Drake WM; Grossman AB; Plowman PN
Eur J Endocrinol; 2009 Dec; 161(6):819-28. PubMed ID: 19773368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
